标题
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 1, Pages 99-110
出版商
American Society for Clinical Investigation
发表日期
2013-12-01
DOI
10.1172/jci46266
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Natural Naive CD4 + CD25 + CD127 low Regulatory T Cell (Treg) Development and Function Are Disturbed in Multiple Sclerosis Patients: Recovery of Memory Treg Homeostasis during Disease Progression
- (2014) Koen Venken et al. JOURNAL OF IMMUNOLOGY
- Expression of ICOS on Human Melanoma-Infiltrating CD4+CD25highFoxp3+ T Regulatory Cells: Implications and Impact on Tumor-Mediated Immune Suppression
- (2014) L. Strauss et al. JOURNAL OF IMMUNOLOGY
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells
- (2012) J. Faget et al. CANCER RESEARCH
- Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells
- (2012) C. Conrad et al. CANCER RESEARCH
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Helios Expression Is a Marker of T Cell Activation and Proliferation
- (2011) Tatiana Akimova et al. PLoS One
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- Melanoma Cells Express ICOS Ligand to Promote the Activation and Expansion of T-Regulatory Cells
- (2010) N. Martin-Orozco et al. CANCER RESEARCH
- Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
- (2010) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells
- (2010) Marc Vocanson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease
- (2010) J. Schulze zur Wiesch et al. JOURNAL OF VIROLOGY
- Proximal human FOXP3 promoter transactivated by NF-κB and negatively controlled by feedback loop and SP3
- (2010) Paul Eckerstorfer et al. MOLECULAR IMMUNOLOGY
- FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
- (2009) I. Kryczek et al. CANCER RESEARCH
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis
- (2009) C Coquerelle et al. GUT
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- PD-1 tempers Tregs in chronic HCV infection
- (2009) Henry Radziewicz et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV
- (2009) Debora Franceschini et al. JOURNAL OF CLINICAL INVESTIGATION
- Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
- (2009) Marianna Sabatino et al. JOURNAL OF CLINICAL ONCOLOGY
- Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression
- (2009) Magis Mandapathil et al. JOURNAL OF IMMUNOLOGICAL METHODS
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Regulatory T cells and treatment of cancer
- (2008) Tyler J Curiel CURRENT OPINION IN IMMUNOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells
- (2008) Susan Brandenburg et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
- (2008) Tomoki Ito et al. IMMUNITY
- CD56brightnatural killer (NK) cells: an important NK cell subset
- (2008) Aurélie Poli et al. IMMUNOLOGY
- Next Generation of Immunotherapy for Melanoma
- (2008) John M. Kirkwood et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- CTLA-4 blockade increases IFN -producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
- (2008) C. I. Liakou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now